Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Nanogrow Biotech

Uruguay-Spain nanobody company pairing single-domain antibodies with local delivery for asthma, colorectal cancer, psoriasis and atopic dermatitis.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Co-development 3
  • Investors 1

Co-development3

An integration or joint product

Use Legit.Health AI scoring as trial endpoints in psoriasis and AD

Dermatology trials depend on severity scores that are subjective and costly to collect. Legit.Health provides CE-marked automated scoring and already partners with dermatology pharma, which could make Nanogrow's early trials cheaper and more credible to licensees.

35%confidence

Evidence from the records

  • “Computer vision and deep learning on skin images, CE-marked as a medical device, with automated severity scores”
  • “allergic asthma, colorectal cancer, psoriasis and atopic dermatitis”
  • “Novartis and Almirall”
If it works
Objective trial endpoints and a door to Legit.Health's pharma partners for licensing talks.
First step
Ask Legit.Health for its clinical-trial service terms and the scores validated for psoriasis and AD.

Test nanobody payloads in the MediChip local-release implant

Both companies bet on local delivery. MediChip is already in colorectal cancer trials, one of Nanogrow's indications; loading a nanobody could create a differentiated combination while BioSapien gains a biologic payload.

25%confidence

Evidence from the records

  • “3D-printed, biodegradable, slow-release implant that can be attached to any tissue”
  • “MediChip in clinical trials for colorectal cancer in the UAE”
  • “Nanobody (sdAb) platform combined with local delivery formulations”
If it works
A joint preclinical study and a co-development option on a local biologic oncology therapy.
First step
Organise a scientific call to check nanobody stability in BioSapien's implant materials.

Evaluate polymer depots for sustained nanobody release

Pleryon designs synthetic polymers for drug delivery and injectable biomaterials, a possible route to longer-acting nanobody formulations. Pleryon gains a biologic payload; Nanogrow gains formulation expertise.

20%confidence

Evidence from the records

  • “Proprietary platforms for designing and controlling the structure of large synthetic and modified natural polymers, for drug delivery and injectable biomaterials”
  • “topical, nebulized, injectable, oral or via DNA/RNA”
If it works
A material-transfer study toward a long-acting local formulation.
First step
Propose an MTA to test one nanobody in a Pleryon polymer.

Investors1

A fund whose thesis fits

Add PharmStars Ventures to the current round

PharmStars invests globally at pre-seed and seed in HealthTech and biotech and backed Argentine network member Cromodata, a regional warm path.

30%confidence

Evidence from the records

  • “Round in progress (closing not confirmed)”
  • “Biotech & life sciences”
If it works
Additional capital toward closing the round and pharma-network access.
First step
Ask Cromodata's founders to introduce Nanogrow to PharmStars.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. VenditekwithPulster.aiCo-development
    Use Pulster NOVA to place and price every new machine

    Vending profitability is a location game, and Pulster sells site assessment and cannibalisation models to 49 Latin American retail brands from the same country. Venditek gets data-driven placement; Pulster gets a new micro-format use case and a joint offer to its retail clients.

    50%
  2. Piezo Sonic CorporationwithProxima RoboticsCo-development
    Run Proxima Compass on Mighty AMR

    Piezo Sonic's differentiation is the rough-terrain chassis and drive, not fleet software; Proxima sells a hardware-agnostic navigation and flow-management layer to robot makers. Bundling Compass on Mighty AMR gives Piezo a proven European navigation stack and gives Proxima an outdoor, all-terrain reference platform beyond indoor AGVs.

    50%
  3. Proxima RoboticswithPiezo Sonic CorporationCo-development
    Port Compass to Piezo Sonic's all-terrain AMR

    Piezo Sonic builds rough-terrain AMRs and sells through Japanese trading houses; Proxima sells navigation software. A port opens outdoor robotics and an Asian channel for Proxima.

    45%
  4. Thistle OÜwithOmniLoc AICo-development
    Integrate GPS-free localisation into Thistle Shield

    Counter-drone engagements happen where GPS is jammed or spoofed, often by the defender itself. OmniLoc's camera-to-satellite matching keeps autonomous platforms positioned without GPS, a direct building block for Thistle's autonomy and a field deployment for OmniLoc.

    40%
  5. RegenratewithFarmbookerCo-development
    Satellite monitoring of contracted fields

    Regenrate guarantees a price before sowing, so it carries yield risk across 1,000+ ha; satellite monitoring of each contracted field improves forecasting and agronomic support. Farmbooker supplies that layer.

    40%
  6. GreenirrwithLayrzCo-development
    Use Layrz's device-agnostic IoT cloud as the data-ingestion layer

    Greenirr needs telematics data from heterogeneous devices; Layrz already normalises many device brands through an API. An integration lets Greenirr onboard fleets in Latin America without custom connectors, and Layrz adds emissions analytics for its asset-tracking customers.

    40%
  7. IKI HealthwithHormonyCo-development
    Combine Hormony's saliva hormone kit with IKI prescriptions

    Menopause programmes need objective hormone data, which Hormony sells as a saliva kit; IKI turns data into clinician-prescribed programmes. A combined test-to-programme offer is stronger for both and opens cross-distribution between Spain and Hormony's markets.

    40%
  8. KetzaiwithMaria EducaçãoCo-development
    Plan-assess loop: Ketzai planning + Maria assessment

    Ketzai produces lesson plans; Maria Educação diagnoses student performance and builds learning paths for publishers and municipalities. Linking assessment results to lesson planning closes the loop that ministries buy, and gives Maria a Spanish-speaking entry route through Ketzai's teacher base.

    40%
  9. Starko OnewithPromptendCo-development
    Verify every Starko PR with deterministic checks

    Starko's promise is a verified pull request, and trust in AI code is the adoption bottleneck. Promptend checks behaviour of AI-generated TypeScript against a spec deterministically, a direct building block that strengthens Starko's claim and gives Promptend a distribution channel.

    40%
  10. ORA TechnologieswithThirdRocCo-development
    Plug ThirdRoc's pay-per-decision credit agents into the super-app

    Embedded credit is the main profit pool of a super-app, but ORA has no documented scoring capability. ThirdRoc sells AI credit decisioning, fraud detection and KYC paid per decision, which fits a variable-cost launch with a licensed Moroccan lender. ThirdRoc gains a North African deployment beyond Fiji.

    40%
  11. aimea.aiwithCoachbot AiCo-development
    From interview evidence to onboarding coaching

    aimea produces documented skills evidence at hiring; Coachbot turns coaching methodologies into AI coaching for HR/L&D. Passing aimea's gap analysis into a CoachBot onboarding plan creates a hire-to-develop offer for the same HR buyer, both Berlin/Hamburg-based.

    35%
  12. BelliwithLayrzCo-development
    Feed IoT asset telemetry into cargo status messaging

    Belli generates and parses IATA status messages; Layrz runs a device-agnostic IoT cloud for vehicles and assets. Wiring Layrz telematics (trucks, dollies, ULD trackers) into Belli's ontology would automate FSU-type status events and give carriers real-time visibility without manual scans, a feature legacy CMS vendors sell as costly add-ons.

    35%
  13. CromodatawithHardshellCo-development
    Certify datasets as leak- and poison-free

    Buyers of AI training data will require assurance against re-identification and contamination. Hardshell scans datasets for these risks; a 'verified' label increases Cromodata's price and trust.

    35%
  14. TerraSparkwithAstrolightCo-development
    Co-develop optical pointing and ground stations for power beaming

    Laser-based power beaming needs the same acquisition, pointing and tracking chain and ground-station know-how that Astrolight has flown. Astrolight gains a second application for its optical stack, while TerraSpark de-risks the transmission link with flight-proven hardware.

    35%
  15. Pleryon TherapeuticswithOcuwell LimitedCo-development
    Portable corneal imaging as a dry-eye trial endpoint

    Pleryon's dry-eye trial needs objective ocular-surface measures; Ocuwell's portable corneal topography device is already used by clinicians. Using OCUTOP in Pleryon's trial sites gives Pleryon richer endpoints and Ocuwell a pharma-trial use case.

    35%
  16. PraxilabswithHi DoctorCo-development
    Joint 'basic science to bedside' simulation bundle for medical schools

    Medical faculties buy both lab simulation (physiology, biochemistry) and clinical-reasoning simulation; PraxiLabs covers the first, Hi Doctor's AI virtual patients the second. A bundled offer raises deal size per faculty and gives each a reference in the other's region (MENA vs Central Asia).

    35%
  17. ProcureProwithSLZCo-development
    Turn MEP design models into procurement packages automatically

    MEP packages are among the most complex and costly to procure, especially on data centres and fabs. SLZ automates MEP design and maintains BIM-based digital twins; feeding SLZ quantities and routing into ProcurePro would pre-populate tender packages and track installed versus committed scope.

    35%
  18. PromptendwithStarko OneCo-development
    Verification gate in an AI feedback-to-PR pipeline

    Starko's AI builds accepted product changes all the way to a verified pull request; Promptend checks that generated TypeScript matches its spec. Embedding Promptend as Starko's verification step strengthens Starko's 'verified PR' promise and gives Promptend a production integration.

    35%
  19. Nanogrow BiotechwithLegit.HealthCo-development
    Use Legit.Health AI scoring as trial endpoints in psoriasis and AD

    Dermatology trials depend on severity scores that are subjective and costly to collect. Legit.Health provides CE-marked automated scoring and already partners with dermatology pharma, which could make Nanogrow's early trials cheaper and more credible to licensees.

    35%
  20. Viz Ai TechnologywithEthermindCo-development
    Capture retiring experts as AI twins on the shop floor

    Viz Ai's core thesis is the 'silver wave' of retiring mechanics; Ethermind builds AI twins of an organisation's best experts. Combining Viz Ai's in-job capture with Ethermind's knowledge-twin engine gives dealers a structured expertise base, not just repair logs.

    35%

Similar profiles

Compatibility score with Nanogrow Biotech

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.